Postes actifs de Sri Mudumba
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PYC THERAPEUTICS LIMITED | Corporate Officer/Principal | - | - |
| Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Sri Mudumba
Anciens postes connus de Sri Mudumba
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
MacuSight, Inc.
 MacuSight, Inc. Pharmaceuticals: MajorHealth Technology MacuSight, Inc. develops and manufactures pharmaceuticals products. The firm engages in developing therapeutics for the treatment of severe ocular diseases and conditions. It offers sirolimus, a therapeutic for the treatment and prevention of wet age-related macular degeneration, as well as for the treatment of diabetic macular edema; and related compounds and other select therapeutics in the eye, as well as minimally-invasive ocular formulations. The company was founded in 2003 and is headquartered in Union City, CA. | Corporate Officer/Principal | 06/07/2010 | - |
Statistiques
Internationale
| Etats-Unis | 2 |
| Australie | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PYC THERAPEUTICS LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
MacuSight, Inc.
MacuSight, Inc. Pharmaceuticals: MajorHealth Technology MacuSight, Inc. develops and manufactures pharmaceuticals products. The firm engages in developing therapeutics for the treatment of severe ocular diseases and conditions. It offers sirolimus, a therapeutic for the treatment and prevention of wet age-related macular degeneration, as well as for the treatment of diabetic macular edema; and related compounds and other select therapeutics in the eye, as well as minimally-invasive ocular formulations. The company was founded in 2003 and is headquartered in Union City, CA. | Health Technology |
- Bourse
- Insiders
- Sri Mudumba
- Expérience